We would love to hear your thoughts about our site and services, please take our survey here.
That all depends on what the highest price they paid in the previous 12 moths, going form the TR1's I'm assuming its around 25p (ish) but could be wrong?
"Should a bidder breach the 30% threshold, it will generally be required to make a mandatory takeover offer for all the shares it does not own. Such offers must be for all cash or have an all cash alternative at a price at least equal to the highest price paid for shares in the previous 12 months."
https://www.addleshawgoddard.com/globalassets/international/asia/guide-to-acquiring-a-uk-public-company.pdf#:~:text=Should%20a%20bidder%20breach%20the%2030%25%20threshold%2C%20it,paid%20for%20shares%20in%20the%20previous%2012%20months.
Click on the "historical data" tab
You never know, I bought 216269 shares at a cost of £1282.68 near the day of suspension so my average is 0.59p, it was always a very long term put for me as its in my LISA, still another 18 years till I can cash it in so in I'm in no hurry, lol, fingers crossed.
Not sure what the relevance of this is but I did notice yahoo finance has the daily share price of Arcturis, not much happening but the price changed from 0.0035 to 0.0051 on the 22nd of Feb?
https://finance.yahoo.com/quote/SSYNF/
i've never heard so many conspiracy theorist's in one place, there has been no mention of revb being taken private other from some impatient pi's on this bb and it would never get voted in by the major share holders as it makes zero business or financial sense whatsoever, the larger share holders with any kind of business acumen play the long game, you won't see boo selling all their shares on the day suspension is lifted like many of the conspi******'s on here, patience will pay.
I'm not holding my breath that we will ever see any value here even if at some point Arcturis was to relist on the LSE, the below is taken from the Times article so anyone holding at suspension will have been diluted to oblivion as part of the refinancing deal.
"As part of the crucial refinancing, Arcturis secured about £24 million through three tranches of convertible shareholder loans, but this largely wiped out existing shareholders, including the NHS trusts and Drayson and his wife."
Apparently this is what we are now waiting for:
"The remaining work to be completed includes a review of working capital and finalisation of internal policy documentation."
How long this will take is anyone's guess?
Hopefully we see the interims next week then the suspension of trading lifted, but even so, I believe the most progress has been made since last years interims so we could do with a more current trading update to actually see how we are doing in the present.
"The Group's unaudited interim financial statements for the 6-month period to 31 August 2022 are now expected be published shortly after the publication of the FY22 accounts.
The Company will continue to work with its Nominated Adviser towards lifting the suspension of trading in its shares as soon as possible following the publication of the interim financial statements, with a further update with respect to the lifting of the suspension being made at that time."
Remember these accounts are from 2021 year ending 2022 so not exactly all that recent, we are now due the accounts last year year ending 2023 and nearly H1 results from this year which would give a much better indication of how we are performing.
Revolution Beauty Plc Chief Executive, Bob Holt OBE, is returning back to his hometown on June 8 as he will be guest of honour at Mahdlo Youth Zone’s next business breakfast.
Sponsored by Mid Communications, businesses, entrepreneurs and students are invited to come along and hear from Bob.
He will be talking about his early years growing up in Oldham where he attended Counthill School, working in his mother’s grocers shops, through to growing his career from 1970 to become known as one of the UK’s most acclaimed businessmen with a flawless history of leadership success.
Bob is most famously known for his pivotal role in the high rise of Mears Group plc.
Since taking control in 1996, he led the business onto the stock market, building an order book value of £3billion and steered the company to its market-leading position.
Bob is currently holding executive and non-executive roles in a number of companies, where he continues to be instrumental in guiding businesses to make beneficial changes that will not only improve the business itself, but will aid communities and have a positive impact on the lives and welfare of others.
Bob said: “Be about doing something, not about being somebody.”
Chris Wareing, Mahdlo Chairman, added: “We are honoured that Bob will be taking time out of his busy schedule to join us.
"We’re looking forward to welcoming our guests to be inspired and motivated by Bob.
"At Mahdlo we believe that every young person deserves the opportunity to reach their full potential, regardless of background or circumstances, and Bob’s story is a fantastic example of what can be achieved.
"I’m very proud to be from Oldham and look forward to exchanging stories with Bob and comparing our experiences of growing up and the changes that have been made in the town over the years.”
The event is free to attend and businesses and individuals can book by visiting: www.mahdloyz.org/events
Its a lot longer than 9 months the accounts we are waiting for are from 2021 year ending 2022 and on top of that we are now due 2022 results year ending 2023.
Its a current trading update that will tell us exactly how we are doing in the present and by the time we are trading again we will be due a full H1 of 2023 update.
Details are vague but it appears Revolution Beauty will be doing a collaboration with Fortnight exclusively for Wallmart, all publicity is good publicity.
https://www.sportskeeda.com/fortnite/rumor-fortnite-announces-surprise-collab-make-brand
Great find init,
"Alex Snow, the former chairman of Exscientia, an AI drug discovery company, has been leading a restructuring of Arcturis to focus on its core patient data business and its partnerships with the NHS. He agrees that NHS data is the “gold standard” in healthcare data, but says that “accessing this anonymised data from multiple sources . . . is not always straightforward”.
Revolution products are now in stock in Primark.
https://www.primark.com/en-gb/a/inspiration/skincare-and-makeup/primark-x-i-heart-revolution